1,536
Views
89
CrossRef citations to date
0
Altmetric
Original Article

Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort

, , , , , , , , & show all
Pages 300-305 | Received 01 Nov 2014, Accepted 21 Nov 2014, Published online: 23 Dec 2014

References

  • Cornell A. The extra-intestinal manifestations of regional ileitis: some comparisons with chronic ulcerative colitis. J Mt Sinai Hosp N Y 1955;22:170–4.
  • Isdale A, Wright V. Seronegative arthritis and the bowel. Baillieres Clin Rheumatol 1989;3:285–301.
  • Bardazzi G, Mannoni A, d’Albasio G, Bonanomi AG, Trallori G, Benucci M, et al. Spondyloarthritis in patients with ulcerative colitis. Ital J Gastroenterol Hepatol 1997;29:520–4.
  • Katz JP, Lichtenstein GR. Rheumatologic manifestations of gastrointestinal diseases. Gastroenterol Clin North Am 1998;27:533–62; v.
  • Mody GM, Cassim B. Rheumatologic manifestations of gastrointestinal disorders. Curr Opin Rheumatol 1998;10:67–72.
  • Hwangbo Y, Kim HJ, Park JS, Ryu KN, Kim NH, Shim J, et al. Sacroiliitis is common in Crohn’s disease patients with perianal or upper gastrointestinal involvement. Gut Liver 2010;4:338–44.
  • Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401–12.
  • Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297–302.
  • Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol 1990;85:711–16.
  • Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996;23:29–34.
  • Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116–22.
  • Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011;106:110–19.
  • Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003;9:2300–7.
  • Rankin GB, Watts HD, Melnyk CS, Kelley MLJr. National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914–20.
  • Shivananda S, Lennard Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
  • Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000;35:1272–7.
  • Lennard Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6; discussion 16-9.
  • Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Maechioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001;36:1307–13.
  • Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011;17:2702–7.
  • Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:63–8.
  • Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 2001;40:1256–61.
  • Calvo P, Pablo L. Managing IBD outside the gut: ocular manifestations. Dig Dis 2013;31:229–32.
  • Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero-Gómez M. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. J Gastroenterol Hepatol 2014;29:291–5.
  • Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2014;40:3–15.
  • McGarity B, Bansi DS, Robertson DAF, Millwardsadler GH, Shepherd HA. Primary sclerosing cholangitis - an important and prevalent complication of crohns-disease. Eur J Gastroenterol Hepatol 1991;3:361–4.
  • Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis - a long-term follow-up-study. Scand J Gastroenterol 1987;22:655–64.
  • Jørgensen KK, Grzyb K, Lundin KEA, Clausen OP, Aamodt G, Schrumpf E, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis 2012;18:536–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.